Rodabe N Amaria Selected Research

Rodabe N Amaria Research Topics

Disease

54	Melanoma (Melanoma, Malignant) 06/2023 - 09/2011
31	Neoplasms (Cancer) 07/2023 - 05/2014
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
4	Disease Progression 01/2018 - 03/2016
3	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2014
2	Blister (Bulla) 07/2023 - 07/2018
2	Exanthema (Rash) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2008
2	Uveal melanoma 11/2018 - 01/2017
1	Bullous Pemphigoid (Pemphigoid) 07/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Anemia 01/2022
1	Neoplasm Micrometastasis 01/2022
1	Diarrhea 01/2022
1	Edema (Dropsy) 01/2022
1	Fatigue 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Nausea 01/2022
1	Urinary Retention 09/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2020
1	Tertiary Lymphoid Structures 01/2020
1	Pathologic Complete Response 01/2020
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Headache (Headaches) 01/2018
1	Fever (Fevers) 01/2018
1	Chills 01/2018
1	Necrosis 12/2017
1	Hemorrhage 12/2017
1	Carcinogenesis 09/2011
1	Multiple Sclerosis 10/2008

Drug/Important Bio-Agent (IBA)

16	Immune Checkpoint InhibitorsIBA 07/2023 - 10/2014
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2014
6	NivolumabIBA 03/2023 - 07/2018
4	IpilimumabIBA 01/2022 - 09/2011
3	Interleukin-2 (IL2)IBA 11/2018 - 01/2015
3	trametinibIBA 01/2018 - 05/2014
3	dabrafenibIBA 01/2018 - 05/2014
2	relatlimabIBA 03/2023 - 11/2022
2	AntigensIBA 01/2022 - 11/2014
2	binimetinibIBA 01/2022 - 01/2020
2	cyclopropapyrroloindoleIBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 10/2021 - 01/2018
2	CytokinesIBA 01/2019 - 01/2015
1	Toll-Like Receptor 4IBA 07/2023
1	Complement System Proteins (Complement)IBA 07/2023
1	pembrolizumabIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ribociclibIBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	atezolizumabIBA 12/2021
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 12/2021
1	Coenzyme A (CoA)IBA 12/2021
1	Keratins (Keratin)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 10/2021
1	Immune Checkpoint ProteinsIBA 10/2021
1	Oxygen (Dioxygen)IBA 09/2021
1	Aurora KinasesIBA 04/2021
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	VemurafenibIBA 01/2021
1	CrizotinibIBA 01/2021
1	AntibodiesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	encorafenibIBA 01/2020
1	T-Lymphocyte Differentiation Antigens (Antigens, Differentiation, T Lymphocyte)IBA 01/2019
1	CathelicidinsIBA 07/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Interleukin-9 (Interleukin 9)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 12/2017
1	Temozolomide (Temodar)FDA LinkGeneric 12/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2016
1	Fluorine-18IBA 02/2016
1	aldesleukin (Proleukin)FDA Link 01/2015
1	Proto-Oncogene Proteins B-rafIBA 05/2014
1	Mitogen-Activated Protein KinasesIBA 05/2014
1	HLA-DR Antigens (HLA-DR)IBA 11/2013
1	Monoclonal AntibodiesIBA 09/2011

Therapy/Procedure

38	Therapeutics 07/2023 - 09/2011
17	Immunotherapy 06/2023 - 01/2015
8	Neoadjuvant Therapy 01/2023 - 07/2018
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 07/2021
2	Radiotherapy 09/2022 - 12/2017
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2018
2	Precision Medicine 01/2017 - 01/2016
1	Ostomy 09/2022
1	Chest Tubes (Chest Tube) 09/2021
1	Blood Transfusion (Blood Transfusions) 09/2021
1	Operative Time 01/2020
1	Injections 07/2018
1	Aftercare (After-Treatment) 07/2018
1	Withholding Treatment 01/2017